Literature DB >> 19269204

Mycobacterium abscessus post-injection abscesses from extrinsic contamination of multiple-dose bottles of normal saline in a rural clinic.

Jun Yuan1, Yufei Liu, Zhicong Yang, Yanshan Cai, Zhiai Deng, Pengzhe Qin, Tiegang Li, Zhiqiang Dong, Ziqiang Yan, Duanhua Zhou, Huiming Luo, Huilai Ma, Xinglin Pang, Robert E Fontaine.   

Abstract

BACKGROUND: We investigated an outbreak of gluteal abscesses following intramuscular (IM) injections given at a clinic in rural China to identify the causative agent, source, and method of exposure.
METHODS: We defined a case as an abscess that appeared at the site of an injection given since June 1, 2006. We compared case rates by injection route, medication, and diluents. We reviewed injection practices, and cultured abscesses and environmental sites for mycobacteria.
RESULTS: From October through December 2006, 5.8% (n=35) of 604 persons who had received injections at the clinic developed a case. All 35 cases occurred in 184 patients (attack rate=19.0%) who had received IM injections with various drugs that had been mixed with normal saline (NS); risk ratio=infinity; p<0.0001. No cases occurred in the absence of NS exposure. We identified Mycobacterium abscessus from eight abscesses and from the clinic water supply, and observed the inappropriate reuse of a 16-gauge needle left in the rubber septum of 100 ml multiple-dose bottles of NS in the clinic. Fourteen percent (n=527) of the 3887 registered residents of this village had been treated with IM drugs over a three-month period, often for minor illnesses.
CONCLUSIONS: This outbreak of M. abscessus occurred from exposure to extrinsically contaminated NS through improper injection practices. Frequent treatment of minor illnesses with IM injections of antibiotics was likely an important contributing factor to the size of this outbreak.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19269204     DOI: 10.1016/j.ijid.2008.11.024

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  7 in total

1.  Gluteal Fibrosis and Its Surgical Treatment.

Authors:  Kristin Alves; Jeffrey N Katz; Coleen S Sabatini
Journal:  J Bone Joint Surg Am       Date:  2019-02-20       Impact factor: 5.284

2.  Mycobacterial infection after cosmetic procedure with botulinum toxin a.

Authors:  Marcela Saeb-Lima; Gerardo-Victor Solis-Arreola; Angel Fernandez-Flores
Journal:  J Clin Diagn Res       Date:  2015-04-01

3.  Mycobacterium chelonae facial infections following injection of dermal filler.

Authors:  Jan M Rodriguez; Yingda L Xie; Kevin L Winthrop; Sean Schafer; Paul Sehdev; Joel Solomon; Bette Jensen; Nadege C Toney; Paul F Lewis
Journal:  Aesthet Surg J       Date:  2013-01-18       Impact factor: 4.283

4.  Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains.

Authors:  Edouard Macheras; Anne-Laure Roux; Sylvaine Bastian; Sylvia Cardoso Leão; Moises Palaci; Valérie Sivadon-Tardy; Cristina Gutierrez; Elvira Richter; Sabine Rüsch-Gerdes; Gaby Pfyffer; Thomas Bodmer; Emmanuelle Cambau; Jean-Louis Gaillard; Beate Heym
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

5.  Case series of mycobacterium abscessus infections associated with a trigger point injection and epidural block at a rural clinic.

Authors:  Jun Young Song; Jung Bin Son; Min Ki Lee; Jin Gwack; Kil Soo Lee; Ji Young Park
Journal:  Epidemiol Health       Date:  2012-01-25

Review 6.  Mycobacterium abscessus: Shapeshifter of the Mycobacterial World.

Authors:  Keenan Ryan; Thomas F Byrd
Journal:  Front Microbiol       Date:  2018-11-01       Impact factor: 5.640

7.  Severe acute respiratory infection risk following glucocorticosteroid treatment in uncomplicated influenza-like illness resulting from pH1N1 influenza infection: a case control study.

Authors:  Xuesen Xing; Shixiong Hu; Meihua Chen; Faxian Zhan; Huihui Liu; Zhang Chen; Hengjiao Zhang; Ge Zeng; Qiaohua Xu; Hong Zhang; Man Liu; Honghui Liu; Lidong Gao; Lijie Zhang
Journal:  BMC Infect Dis       Date:  2019-12-26       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.